Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/133582| Title: | Pharmacogenetics of ugt genes in North African populations |
| Author: | Gaibar, M. Novillo, A. Romero-Lorca, A. Esteban i Torné, Maria Esther Fernández-Santander, A. |
| Keywords: | Enzims Àfrica del Nord Farmacogenètica Enzymes North Africa Pharmacogenetics |
| Issue Date: | 31-Jul-2018 |
| Publisher: | Springer Nature |
| Abstract: | Cytochrome P450 (CYP450), sulfotransferase (SULT), and glucuronidase (UGT) enzymes play roles in the phase I and phase II metabolism of most clinically prescribed drugs. As polymorphisms in these genes may alter enzyme activities, most prescribed drugs will differ in their efficacy and side effects. In prior work, we showed that besides polymorphisms in CYP450, those in SULT and UGT also give rise to different serum levels of some drug metabolites than detected in wild-type carriers of the genes [1]. [...] |
| Note: | Reproducció del document publicat a: https://doi.org/10.1038/s41397-018-0034-4 |
| It is part of: | The Pharmacogenomics Journal, 2018, vol. 18, p. 609-612 |
| URI: | http://hdl.handle.net/2445/133582 |
| Related resource: | https://doi.org/10.1038/s41397-018-0034-4 |
| ISSN: | 1470-269X |
| Appears in Collections: | Articles publicats en revistes (Institut de Recerca de la Biodiversitat (IRBio)) Articles publicats en revistes (Biologia Evolutiva, Ecologia i Ciències Ambientals) |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 682037.pdf | 275.51 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License
